Home / Research and experimental development on biotechnology (except medical and veterinary science)

SYNTBIOS PTE. LTD.

Live CompanyUEN 202245255WLocal Company

SYNTBIOS PTE. LTD. is a local company in Singapore with UEN 202245255W. It was registered on 20 Dec 2022, 3 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202245255W
StatusLive Company
Entity typeLocal Company, Exempt Private Company Limited by Shares
Registered20 Dec 2022
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity46461 Wholesale of medicinal and pharmaceutical products (Western)
Address57 GENTING LANE, #10-00, GANI BUILDING, Singapore 349564
28 companies at this address
AreaGeylang · District 13 (Macpherson, Braddell)
Nearest stationGeylang Bahru MRT, about 774 m
Officers2
Last annual return10 Jun 2026

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.